Baxter suffers loss in contaminated heparin case; Caraco delisted, merges with Sun;

> Baxter International has lost the first case in its ongoing legal dispute over the 2007-2008 heparin contamination. Item

> Quality-challenged Caraco Pharmaceutical Laboratories in Detroit has been removed from the New York Stock Exchange after voting to become a private company and merge with majority shareholders Sun Pharmaceutical Industries, Sun Pharma Global and Sun Laboratories Inc. Story

> There were 1,693 known incidents of counterfeit medicines last year, a rise of 7% over the 2009 figure. News

> GlaxoSmithKline plans to hire about 30 new employees at its Hamilton facility due to demand for its cervical cancer vaccine. Story

> West Pharmaceutical Services has begun construction on a compression molding plant in the Shanghai Qingpu Industrial Zone adjacent to the company's injection molding facility. West release

> The Healthcare Industry Group of professional service provider Alvarez & Marsal has allied with consultancy Rondaxe to provide manufacturing, supply chain and compliance services to drugmakers. Alvarez & Marsal release

> Cardinal Health has signed a three-year agreement with pharmacy benefit manager Prime Therapeutics to continue servicing its PrimeMail mail-service pharmacy. Cardinal Health/Prime announcement

> The six key challenges to safety risk management stem from data, communication, organization, talent, money and strategy. Interview (reg. req.)

Suggested Articles

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot. 

The FDA recently asked five drug manufacturers to recall the commonly used diabetes med metformin. With COVID-19 raging, is metformin just the start?

The antidepressant Zoloft and its generics are in short supply as the COVID-19 pandemic has caused higher demand and manufacturing interruptions.